Navigation Links
German Research Minister Schavan: 'Rapid knowledge transfer can safe lives'
Date:6/10/2009

This release is available in German.

No progress without research this is particularly true for cancer medicine. The chances of cure for those affected can only be further increased if research results are swiftly transferred from the laboratory into clinical practice. Framework conditions for this research transfer, also called translational research, will now be optimized in Germany. Last Tuesday, German Research Minister Annette Schavan, Friedrich Carl Janssen, Chairman of German Cancer Aid (Deutsche Krebshilfe), and Professor Dr. Otmar D. Wiestler, Scientific Director of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) presented the "National Consortium for Translational Cancer Research" in Berlin.

"Each year, more than 436,000 people in Germany are newly diagnosed with cancer, 210,000 patients die of cancer every year. Therefore, it is important to translate the latest findings of cancer research even more rapidly into patient care. To this end, we have founded the National Consortium for Translational Cancer Research," Schavan said. "We intend to further strengthen Germany's leading role in cancer research."

The consortium is established on the initiative of the Federal Ministry of Education and Research (Bundesministerium fr Bildung und Forschung, BMBF), German Cancer Aid (Deutsche Krebshilfe) and the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). The financial resources needed for the whole consortium over a period of ten years amount to 400 million euros.

"It has always been an endeavor of German Cancer Aid as a private organization to implement large projects jointly with public entities in order to create synergies. Apart from the fact that it makes sense for important private initiatives to collaborate with political institutions, ambitious projects can only be shouldered together. The joint project presented today is an excellent, future-oriented example of such a partnership," Janssen emphasized.

Key tasks of the national consortium include the creation and use of effective translational research units at partnering sites within a network throughout Germany. The DKFZ in Heidelberg as the core research center will collaborate with selected partners at university hospitals at up to six sites. "In this collaboration, DKFZ will be supported by excellent partners that will provide access to patients, samples and an effective clinical environment. In return, the sites will be given access to DKFZ's research programs," said Schavan. The sites will be selected by a committee of international experts by early 2010.

"Cancer research in Germany has gained an enormous amount of new findings in recent years. We understand more and more of the fundamental causes and development processes of cancer what matters now is that we transport this knowledge as swiftly and directly as possible into the clinical care of cancer patients," Professor Otmar D. Wiestler explained. "At the German Cancer Research Center, we have been able to gather a unique body of expertise for tight networking among basic research and clinical practice thanks to the foundation of the National Center for Tumor Diseases. Thus, we have created the best prerequisites for coordinating and advancing translational, i.e. application-oriented, cancer research in Germany under the leadership of our Center."

At the same time, research minister Schavan announced that the Federal Ministry of Education and Research and German Cancer Aid will jointly support the participation of a German research consortium in the International Cancer Genome Consortium (ICGC). Both partners will jointly provide funds of approximately 15 million euros over a period of five years. This is intended as a contribution to the fight against tumor diseases with particularly high mortality. The ICGC aims to analyze the genetic changes in tumors of all human organ systems in order to facilitate and customize new and better applications in the areas of diagnosis, treatment and prevention of the respective cancer types. The results will rapidly be made available to the research community as a basis for further research work. The project is planned to be launched in fall 2009. The ICGC is a large-scale biomedical project in which leading cancer researchers have joined forces.


'/>"/>

Contact: Dr. Stefanie Seltmann
presse@dkfz.de
49-622-142-2854
Helmholtz Association of German Research Centres
Source:Eurekalert

Related biology news :

1. Measurement Specialties, Inc. Announces Impact of German Business Tax Reform 2008 Resulting in Lower Combined German Tax Rate - Impacts 2Q08 Reported Financial Results
2. Japanese and German researchers meet to discuss climate change
3. Qualifying date rule hinders German stem cell research
4. DFG welcomes decision on stem cell research by German parliament
5. Outstanding German-Polish scientific cooperation
6. Excavated Jericho bones may help Israeli-Palestinian-German team combat tuberculosis
7. Prominent German biologist wins EMBO Communication Award
8. EMBO recognizes German zoologist for public communication
9. Where do the fattest Germans live?
10. LOHAFEX: An Indo-German iron fertilization experiment
11. Joint statement by German science organizations on green genetic engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... ... and Markets has announced the addition of the "Global Military Biometrics ... forecasts the global military biometrics market to grow at a CAGR of ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/15/2016)... 15, 2016  There is much more to innovative ... the engine. Continental will demonstrate the intelligence of today,s ... . Through the combination of the keyless entry ... biometric elements, the international technology company is opening up ... authentication. "The integration of biometric elements brings ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... ... January 20, 2017 , ... The two newest companies to join ... patients. Vironika, a spin out from The Wistar Institute, and Sanguis, launched by a ... 3624 Market Street. , Vironika is developing a treatment for a chronic viral ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... the next evolution in spinal fusion, the MISquito Percutaneous Pedicle Screw System ... competition, SpineFrontier is focused on technique driven product solutions that provide maximum ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 ... Inc., a privately-held immunotherapeutics company targeting infectious diseases, ... for the merger of PharmAthene and Altimmune in ... Venture Fund, HealthCap, Truffle Capital and Redmont Capital. ... diversified immunotherapeutics company with four clinical stage and ...
Breaking Biology Technology: